Financial News

Recent Quotes

My Watchlist

Indicators

Overview

Here’s why the FDA may approve a Covid-19 vaccine before the November elections, according to Jefferies’ biotech-research team

By: MarketWatch

June 19, 2020 at 06:08 AM EDT

If true, any approval may not actually benefit a vaccine company, but instead other parts of the stock market.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Financial News

Here’s why the FDA may approve a Covid-19 vaccine before the November elections, according to Jefferies’ biotech-research team

Popular Pages